Lv7
4985 积分 2021-05-12 加入
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
2天前
已完结
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
2天前
已完结
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Review of calculation of conditional power, predictive power and probability of success in clinical trials with continuous, binary and time-to-event endpoints
8个月前
已完结
Backfilling Patients in Phase I Dose Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
8个月前
已完结
Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis
9个月前
已完结
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism
9个月前
已完结
【书】Human Insulin: Clinical Pharmacological Studies in Normal Man
3年前
已完结
【书】Human Insulin: Clinical Pharmacological Studies in Normal Man
3年前
已关闭
Early completion of phase I cancer clinical trials with Bayesian optimal interval design
3年前
已完结
皖公网安备34019202002308
